Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics

MOUNTAIN VIEW, Calif. -- Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), an innovation platform dedicated to discovering, developing, and deploying promising health innovations, today announced that it had entered into a third amending agreement with Appili Therapeutics, Inc. (TSX: APLI; OTCPink: APLIF) (“Appili”), a biopharmaceutical company focused on developing innovative treatments and vaccines to combat some of the most challenging infectious diseases and potential bioterrorism threats. Read More

Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics

Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics

Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics

Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics

Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics